Denne side blev automatisk oversat, og nøjagtigheden af ​​oversættelsen er ikke garanteret. Der henvises til engelsk version for en kildetekst.

Effectiveness of Shared Decision Making(SDM)on Patients With Poor Control Type 2 Diabetes (SDM)

4. september 2026 opdateret af: Fooyin University
The study is a pilot study, using a convenient sampling method, targeting at outpatient patients with type 2 diabetes who participate in the diabetes co-care program and poor blood sugar control as the research subjects, and randomly assigned. The number of samples is expected to receive 30 patients in each group. The attrition rate estimates about 20%, so there should be 76 people in total, and 38 people in each group. The experimental group was involved in SDM health education; the control group was involved in routine health education. After the implementation of the measures, the self-efficacy and health promotion behavior changes of the two groups and the effectiveness of disease control (glycated hemoglobin, body mass index, waist circumference) were tracked.

Studieoversigt

Status

Afsluttet

Betingelser

Intervention / Behandling

Detaljeret beskrivelse

Background Diabetes and hyperglycemia not only increase the risk of complications of cardiovascular disease and lead to a situation involving exposure to danger of death. Meanwhile, the patient's self-management is one of the key factors affecting the quality control of blood sugar. Thereby, Shared Decision Making (SDM) is a patient-centered medical implementation method that healthcare professionals and patients jointly participate in treatment decision-making to reach a consensus, which can stimulate the health care ability of participants to achieve treatment goals.

Purpose: This research aims to implement the SDM model based on self-efficacy theory through individualized decision-making to strengthen the behavioral motivation of diabetic patients and finally, to improve the patient's health promotion behavior and the effectiveness of blood sugar control.

Method: Study Type: Interventional Actual Enrollment:76 participants Allocation:Randomized Intervention Model:Parallel Assignment Masking:Single(Participant)

Expected results:

It is hoped that the implementation of SDM model will be used to strengthen the behavioral motivation of diabetic patients through individualized decision-making, and to confirm whether it can effectively improve the patient's health behavior and the effectiveness of disease control.

Undersøgelsestype

Interventionel

Tilmelding (Faktiske)

70

Fase

  • Ikke anvendelig

Kontakter og lokationer

Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.

Studiesteder

    • Taiwan
      • Tainan, Taiwan, Taiwan, 709204
        • An Nan Hospition-China Medical University

Deltagelseskriterier

Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.

Berettigelseskriterier

Aldre berettiget til at studere

  • Voksen
  • Ældre voksen

Tager imod sunde frivillige

Ingen

Beskrivelse

Inclusion Criteria:

  • Aged>20y/o
  • Diagnosed by a physician as type 2 diabetes
  • The Diabetes Participated in the Diabetes Shared Care Network
  • Glycosylated hemoglobin (A1C)> 7.5%
  • Can communicate in Chinese or Taiwanese.

Exclusion Criteria:

  • People with mental or cognitive impairment who cannot communicate
  • Health Literacy score lower than 6 points

Studieplan

Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.

Hvordan er undersøgelsen tilrettelagt?

Design detaljer

  • Primært formål: Forebyggelse
  • Tildeling: Randomiseret
  • Interventionel model: Parallel tildeling
  • Maskning: Enkelt

Våben og indgreb

Deltagergruppe / Arm
Intervention / Behandling
Ingen indgriben: Control group:as usual care
The control group received as usual care.
Eksperimentel: Experimental group:The intervention of SDM
The experimental group received the intervention of SDM 3 times for 3 months,
The experimental group received the intervention of SDM 3times/month for 3months, then follow the health promotion behavior compliance by phone once a month.

Hvad måler undersøgelsen?

Primære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Diabetes self-efficacy scale
Tidsramme: Pre-test (baseline)
assesses the confidence of diabetes patients in their ability to manage their diet, blood sugar, and physical exercise
Pre-test (baseline)
Diabetes self-efficacy scale
Tidsramme: 1 months after intervnetion
assesses the confidence of diabetes patients in their ability to manage their diet, blood sugar, and physical exercise
1 months after intervnetion
Diabetes self-efficacy scale
Tidsramme: 3 months after intervnetion
assesses the confidence of diabetes patients in their ability to manage their diet, blood sugar, and physical exercise
3 months after intervnetion
Diabetes health literacy scale
Tidsramme: Pre-test (baseline)
A disease-specific scale to measure functional, communicative and critical health literacy in primary care
Pre-test (baseline)
Diabetes health literacy scale
Tidsramme: 3 months after intervnetion
A disease-specific scale to measure functional, communicative and critical health literacy in primary care
3 months after intervnetion
Diabetes health promotion scale
Tidsramme: Pre-test (baseline)
A self-report study instrument that includes the health profile, and Diabetes Health Promotion Scale
Pre-test (baseline)
Diabetes health promotion scale
Tidsramme: 1 months after intervnetion
A self-report study instrument that includes the health profile, and Diabetes Health Promotion Scale
1 months after intervnetion
Diabetes health promotion scale
Tidsramme: 3 months after intervnetion
A self-report study instrument that includes the health profile, and Diabetes Health Promotion Scale
3 months after intervnetion
Hemoglobin A1C (HbA1c) Test
Tidsramme: 3 months after intervnetion
An HbA1c test shows what the average amount of glucose attached to hemoglobin has been over the past three months.
3 months after intervnetion
Hemoglobin A1C (HbA1c) Test
Tidsramme: Pre-test (baseline)
An HbA1c test shows what the average amount of glucose attached to hemoglobin has been over the past three months
Pre-test (baseline)

Samarbejdspartnere og efterforskere

Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.

Sponsor

Datoer for undersøgelser

Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.

Studer store datoer

Studiestart (Faktiske)

12. maj 2020

Primær færdiggørelse (Faktiske)

30. oktober 2020

Studieafslutning (Faktiske)

30. juni 2021

Datoer for studieregistrering

Først indsendt

14. marts 2022

Først indsendt, der opfyldte QC-kriterier

4. september 2026

Først opslået (Faktiske)

9. september 2026

Opdateringer af undersøgelsesjournaler

Sidste opdatering sendt (Faktiske)

9. september 2026

Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier

4. september 2026

Sidst verificeret

1. september 2021

Mere information

Begreber relateret til denne undersøgelse

Andre undersøgelses-id-numre

  • FooyinU

Plan for individuelle deltagerdata (IPD)

Planlægger du at dele individuelle deltagerdata (IPD)?

INGEN

Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter

Studerer et amerikansk FDA-reguleret lægemiddelprodukt

Ingen

Studerer et amerikansk FDA-reguleret enhedsprodukt

Ingen

Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .